Literature DB >> 25130833

[Effect of umbilical cord MSC infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation].

Dong-Mei Han1, Zhi-Dong Wang1, Li Ding1, Xiao-Li Zheng1, Hong-Min Yan1, Mei Xue1, Ling Zhu1, Jing Liu1, Heng-Xiang Wang2.   

Abstract

This study was purposed to investigate the effect of umbilical cord mesenchymal cells (UC-MSC) infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation (hi-HSCT). The infection of 83 patients underwent hi-HSCT was detected and analysed, among them 42 patients received haploidentical hi-HSCT, 41 received hi-HSCT combined with UC-MSC infusion. The results showed that 31 cases (73.81% ± 6.78%) were infected by cytomegalovirus and 21 cases in patients received hi-HSCT experienced pulmonary infections, including infections of fungal, virus, bacteria, tubercle bacillus, PCP and so on, the incidence rate was (50 ± 7.72)%; the infection of cytomegalovirus (CMV) was found in 31 cases, the incidence rate was (78.05 ± 6.46)%. In patients received hi-HSCT combined with UC-MSC, only 15 patients experienced pulmonary infection, the incidence rate was (36.59 ± 7.52)%, and the infection of cytomegalovirus (CMV) was observed in 32 patients, the incidence rate was (78.05 ± 6.46)%. There was no obvious statistical difference between two groups(P > 0.05). It is concluded that the UC-MSC infusion not increases the infection rate in hi-HSCT.

Entities:  

Mesh:

Year:  2014        PMID: 25130833     DOI: 10.7534/j.issn.1009-2137.2014.04.037

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  4 in total

1.  Efficacy and mechanisms underlying the effects of allogeneic umbilical cord mesenchymal stem cell transplantation on acute radiation injury in tree shrews.

Authors:  De-Bin Guo; Xiang-Qing Zhu; Qing-Qing Li; Gao-Mi-Yang Liu; Guang-Ping Ruan; Rong-Qing Pang; Yu-Hao Chen; Qiang Wang; Jin-Xiang Wang; Ju-Fen Liu; Qiang Chen; Xing-Hua Pan
Journal:  Cytotechnology       Date:  2018-07-31       Impact factor: 2.058

2.  Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.

Authors:  Sheila A Fisher; Antony Cutler; Carolyn Doree; Susan J Brunskill; Simon J Stanworth; Cristina Navarrete; John Girdlestone
Journal:  Cochrane Database Syst Rev       Date:  2019-01-30

3.  Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats.

Authors:  Jae Chul Lee; Kwan Chang Kim; Yoon Sun Yang; Wonil Oh; Soo Jin Choi; Soo Young Choe; Young Mi Hong
Journal:  Anat Cell Biol       Date:  2014-12-23

4.  [Efficacy and security of matched unrelated donor hematopoietic stem cell transplant with transfusion of multipotent mesenchymal cells in pediatric severe aplastic anemia].

Authors:  L Wang; H X Wang; L Zhu; X L Zheng; Z D Wang; H M Yan; L Ding; D M Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.